AkzoNobel Calls Shareholder Meeting for August 5 to Vote on Axalta Merger
AXTA sits 38% above its 52-week low of $24.937.
Summary
AkzoNobel has issued a notice for its Extraordinary General Meeting on August 5, 2026, for shareholders to vote on the merger with Axalta Coating Systems, including share issuance and board appointments for the combined entity.
Key Events · M&A and Partnerships · AXTA
-
Shareholder Vote Scheduled
AkzoNobel will hold an Extraordinary General Meeting on August 5, 2026, for its shareholders to vote on the proposed all-share merger with Axalta.
-
Merger Resolutions Detailed
The EGM agenda includes resolutions for approving the merger agreement, amending articles of association, authorizing share issuance for consideration, and appointing the combined company's board of directors.
-
Final Stage of Merger
This filing, alongside Axalta's definitive proxy statement and the recent effectiveness of the Form F-4, indicates the merger is in its final stages awaiting shareholder approval.
Analysis · AXTA · Industrial Applications And Services
This filing from AkzoNobel details the agenda for its Extraordinary General Meeting on August 5, 2026, where shareholders will vote on the proposed all-share merger with Axalta. This follows the SEC's declaration of effectiveness for the Form F-4 registration statement yesterday and Axalta's definitive proxy filing today, marking the final stages before the shareholder votes to approve the transaction.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 40.7% of the 388 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.42%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AXTA was trading at $34.52 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $24.94 to $35.72. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.